Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded Last action
- Contract number
- SPE2DR26FNR5L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,184
Award facts
- Contract value 100% obligated
- $3,183.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,183.92 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL on January 13, 2026, with an ultimate completion date of January 14, 2026. This non-competitive delivery order was placed at the awardee's place of performance in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains through competitive and non-set-aside contracts. This particular delivery order for HUMIRA, a widely-used biologic medication for autoimmune conditions, exemplifies the company's ongoing role in fulfilling essential pharmaceutical needs across the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FNR5L?
SPE2DR26FNR5L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FNR5L worth?
The government has obligated $3,184 on SPE2DR26FNR5L.
Is contract SPE2DR26FNR5L an order under another contract?
Yes. SPE2DR26FNR5L is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNR5L competed?
The extent of competition for SPE2DR26FNR5L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award